Changes in cardiac phenotype in hypertrophy and failure: From receptor to gene

Heart Failure Reviews

Volumn 2, Issue 2, 1997, Pages 95-106

  Van Heugten, Han A A ^a   Lamers, Jos M J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Gene expression; Heart failure; Hypertrophy; Phenotype; Signal transduction

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

CELL DIVISION; CELL SIZE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART HYPERTROPHY; HEART PERFORMANCE; NONHUMAN; PHENOTYPE; PROTEIN DOMAIN; RECEPTOR GENE; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 0031462716     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009719926882     Document Type: Review

References (74)

1. Schwartz K, Carrier L, Mercadier J-J, Lompre A-M, Boheler KR. Molecular phenotype of the hypertrophied and failing myocardium. Circulation 1993;87:VII5-VII10.
2. van Heugten HAA, de Jonge HW, Bezstarosti K, Sharma HS, Verdouw PD, Lamers JMJ. Intracellular signalling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes. Ann NY Acad Sci 1995;752:343-352.
3. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon DS, Yen R, Chien KR, Baker JB, Wood WI. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995;92:1142-1146.
4. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shiriri M, Koike A, Nogami A, Marumo F. Insulinlike growth factor-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-1721.
5. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, Sugden PH. Endothelin-1 and fibroblast growth factor stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signalling pathways leading to cardiac hypertrophy. J Biol Chem 1994;269:1110-1119.
6. Boheler KR, Schwartz K. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 1992;2:176-182.
7. Braunwald F. The Myocardium: Failure and Infarction. New York: New York H.P. Publishing, 1974;409-412.
8. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circulation 1994;74:555-564.
9. Hasenfuss G, Just H. Myocardial phenotypic changes in heart failure: cellular and subcellular adaptations and their functional significance. Br Heart J 1994;72:S10-17.
10. Townsend PJ, Barton PJR, Yacoub MH, Farza H. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol 1995; 27:2223-2236.
11. Zahler R, Gilmore-Hebert M, Sun W, Benz EJ. Na,K-AT-Pase isoform gene expression in normal and hypertrophied dog heart. Basic Res Cardiol 1996;91:256-266.
12. Bundgaard H, Kjeldsen K. Human myocardial Na,K-AT-Pase concentration in heart failure. Mol Cell Biochem 1996; 163/164:277-283.
13. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res 1996;31:48-54.
14. 2+ exchanger in failing human myocardium. Circulation 1996; 94:992-1002.
15. + channel genes in left ventricular remodelled myocardium after experimental myocardial infarction. Circ Res 1996;79:669-675.
16. Marks AR. Expression and regulation of ryanodine receptor/calcium release channels. Trends Cardiovasc Med 1996; 6:130-135.
17. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996;94:1894-1901.
18. Rouet-Bemzineb P, Mohammadi K, Pérennec J, Poyard M, Bouanani NEH, Crozatier B. Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 1996;79:153-161.
19. 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 1996;28:1-10.
20. Nozawa Y, Miyake H, Haruno A, Yamada S, Uchida S, Ohkura T, Kimura R, Suzuki H, Hoshino T. Down-regulation of angiotensin II receptors in hypertrophied human myocardium. Clin Exp Pharmacol Physiol 1996;23:514-518.
21. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-1094.
22. Thoenis M, Förstermann U, Tracey WR, Bleese NM, Nüssler AK, Scholz H, Stein B. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 1996;28:165-169.
23. Doud SK, Pan L-X, Carleton S, Marmorstein S, Siddiqui MAQ. Adaptional response in transcription factors during development of myocardial hypertrophy. J Mol Cell Cardiol 1995;27:2359-2372.
24. 2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 1996;163/164:285-290.
25. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 1996;31:625-632.
26. 2+-ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 1996;74:321-332.
27. Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res 1991; 69:266-276.
28. Zheng J-S, Boluyt MO, O'Neil L, Crow MT, Lakatta EG. Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res 1994;74:1034-1041.
29. Yokota N, Bruneau BG, Fernande BE, de Bold ML, Piazza LA, Eid H, de Bold AJ. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens 1995; 8:301-310.
30. 1 receptor subtype. Circ Res 1993;73:413-23.
31. Sadoshima J-I, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 1993;73:424-438.
32. A- receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol 1994;23:344-347.
33. 1A-adrenergic receptor sub-type mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 1993;268:15374-15380.
34. Sadoshima J-I, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75:977-984.
35. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II partly mediates mechanical stressinduced cardiac hypertrophy. Circ Res 1995;77:258-265.
36. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem 1996; 271:3221-3228.
37. Chen Q, Lin TH, Der CJ, Juliano RL. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of ras. J Biol Chem 1996;271:18122-18127.
38. Zheng J-S, Boluyt MO, Long X, O'Neill L, Lakatta EG, Crow MT. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res 1996;78:525-535.
39. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-355.
40. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994;89:2198-2203.
41. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. Mol Cell Cardiol 1996;28:507-517.
42. Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z, Ying W, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo an inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994;89:2204-2211.
43. Susie D, Nunez E, Frohlich ED, Prakash O. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension 1996;28:265-268.
44. Ray K, Hanse CA, Robishaw JD. Gβγ-mediated signaling in the heart: implications of β and γ subunit heterogeneity. Trends Cardiovasc Med 1996;6:115-121.
45. Bogoyevitch MA, Sugden PH. Review. The role of protein kinases in adaptional growth of the heart. Int J Biochem Cell Biol 1996;28:1-12.
46. 2+ entry blocker in cultured rat ventricular myocytes. Cell Calcium 1995; 18:515-525.
47. Pucéat M, Vassort G. Signalling by protein kinase C isoforms in the heart. Mol Cell Biochem 1996;157:65-72.
48. Decock JB, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ. Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett 1994; 356:275-278.
49. Page C, Doubell AF. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem 1996; 157:49-57.
50. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 1995; 77:1040-1052.
51. Takano H, Komuro I, Zou Y, Kudoh S, Yamazaki T, Yazaki Y. Activation of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes. FEBS Lett 1996;379:255-259.
52. Sugden PH, Bogoyevitch MA. Endothelin-1-dependent signaling pathways in the myocardium. Trends Cardiovasc Med 1996;6:87-94.
53. Quintaje SB, Church DJ, Rebsamen M, Valloton MB, Hemmings BA, Lang U. Role of protein phosphatase 2A in the regulation of mitogen-activated protein kinase activity in ventricular cardiomyocytes. Biochem Biophys Res Commun 1996;221:539-547.
54. Chuang CF, Ng SY. Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett 1994;346:229-234.
55. Thornburn A, Thornburn J, Chen S-Y, Powers S, Shubeita HE, Feramisco JR, Chien KR. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 1993;268:2244-2249.
56. Gillespie-Brown J, Fuller SJ, Bogoyevitch MA, Cowley S, Sugden PH. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem 1995;270:28092-28096.
57. 2-terminal kinase in cultured cardiac myocytes or neonatal rats. Circ Res 1997;80:139-146.
58. Hirato H, Yoshida K, Taga T, Kishimoto T. gp130 signaling pathways: recent advances and implications for cardiovascular disease. Trends Cardiovasc Med 1996;6:109-115.
59. Touyz RM, Sventek P, Lariviére R, Thibault G, Fareh J, Reudelhuber T, Schiffrin EL. Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 1996;27:1090-1096.
60. 2+-dependent signaling. Circ Res 1995;76:1-15.
61. Arai H, Escobedo JA. Angiotensin II type 1 receptor signals through raf-1 by a protein kinase C-dependent, ras-independent mechanism. Mol Pharmacol 1996;50:522-528.
62. Eskildsen-Helmond YEG, van Heugten HAA, Lamers JMJ. Regulation and functional significance of phospholipase D in myocardium. Mol Cell Biochem 1996;157:39-48.
63. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz EJ. Role of c-src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 1996;271:19443-19450.
64. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 1996;314:115-121.
65. Post GR, Goldstein D, Thureau DJ, Glembotski CC, Brown JH. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 1996;271:8452-8457.
66. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach down-regulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 1996;78:954-961.
67. Thornburn J, Frost JA, Thorburn A. Mitogen-activated protein kinase mediates changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol 1994;126:1565-1572.
68. Sah VP, Hoshijima M, Chien KR, Brown JH. Rho is required for Gαq and α1-adrenergic receptor signaling in cardiomyocytes. Dissociation of ras and rho pathways. J Biol Chem 1996;271:31185-31190.
69. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 1996;94:2626-2632.
70. Aoyagi T, Izumo S. Mapping of the pressure response element of the c-fos gene by direct DNA injection into beating hearts. J Biol Chem 1993;268:27176-27179.
71. Kovacic-Milivojevic B, Gardner DG. Regulation of the human atrial natriuretic peptide gene in atrial cardiocytes by the transcription factor AP-1. Am J Hypertens 1993; 6:258-263.
72. Kovacic-Milivojevic B, Gardner DG. Fra-1, a fos gene family member that activates atrial natriuretic peptide gene transcription. Hypertension 1995;25:679-682.
73. Knowlton KU, Baracchini E, Ross RS, Harris AN, Henderson SA, Evans SM, Glembotski CC, Chien KR. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during α-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem 1991;266:7759-7768.
74. 1-adrenergic induction of skeletal α-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem 1995;270:410-417.